Quick Answer
Autolus Therapeutics plc reported Total Revenue of $75.39 million for fiscal year 2025.
Autolus Therapeutics plc Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $75.39M | +644.9% |
| 2024 | $10.12M | +496.0% |
| 2023 | $1.70M | -41.6% |
| 2019 | $2.91M | +106.7% |
| 2018 | $1.41M | -16.9% |
| 2017 | $1.69M | +39.7% |
| 2016 | $1.21M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $21.19M | — | +1.3% |
| June 30, 2025 | $20.92M | — | +132.9% |
| March 31, 2025 | $8.98M | -11.0% | — |
| September 30, 2024 | $0.00 | — | — |
| June 30, 2024 | $0.00 | — | -100.0% |
| March 31, 2024 | $10.09M | — | — |
- Autolus Therapeutics plc showed an increase of +644.9% in Total Revenue compared to the prior fiscal year.
- Over the 2016–2025 period, Autolus Therapeutics plc’s total revenue has grown by 6120.1% (from $1.21 million to $75.39 million).
- The most recent figure is from Autolus Therapeutics plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: